• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖时代的癌症恶病质:骨骼肌消耗是一个强大的预后因素,与体重指数无关。

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

机构信息

University of Alberta, Edmonton, Alberta, Canada.

出版信息

J Clin Oncol. 2013 Apr 20;31(12):1539-47. doi: 10.1200/JCO.2012.45.2722. Epub 2013 Mar 25.

DOI:10.1200/JCO.2012.45.2722
PMID:23530101
Abstract

PURPOSE

Emerging evidence suggests muscle depletion predicts survival of patients with cancer.

PATIENTS AND METHODS

At a cancer center in Alberta, Canada, consecutive patients with cancer (lung or GI; N = 1,473) were assessed at presentation for weight loss history, lumbar skeletal muscle index, and mean muscle attenuation (Hounsfield units) by computed tomography (CT). Univariate and multivariate analyses were conducted. Concordance (c) statistics were used to test predictive accuracy of survival models.

RESULTS

Body mass index (BMI) distribution was 17% obese, 35% overweight, 36% normal weight, and 12% underweight. Patients in all BMI categories varied widely in weight loss, muscle index, and muscle attenuation. Thresholds defining associations between these three variables and survival were determined using optimal stratification. High weight loss, low muscle index, and low muscle attenuation were independently prognostic of survival. A survival model containing conventional covariates (cancer diagnosis, stage, age, performance status) gave a c statistic of 0.73 (95% CI, 0.67 to 0.79), whereas a model ignoring conventional variables and including only BMI, weight loss, muscle index, and muscle attenuation gave a c statistic of 0.92 (95% CI, 0.88 to 0.95; P < .001). Patients who possessed all three of these poor prognostic variables survived 8.4 months (95% CI, 6.5 to 10.3), regardless of whether they presented as obese, overweight, normal weight, or underweight, in contrast to patients who had none of these features, who survived 28.4 months (95% CI, 24.2 to 32.6; P < .001).

CONCLUSION

CT images reveal otherwise occult muscle depletion. Patients with cancer who are cachexic by the conventional criterion (involuntary weight loss) and by two additional criteria (muscle depletion and low muscle attenuation) share a poor prognosis, regardless of overall body weight.

摘要

目的

新出现的证据表明肌肉减少预测癌症患者的生存。

方法

在加拿大艾伯塔省的一个癌症中心,连续评估了患有癌症(肺癌或胃肠道癌;N=1473 例)的患者在就诊时的体重减轻史、腰椎骨骼肌指数和 CT 扫描的平均肌肉衰减(亨氏单位)。进行了单变量和多变量分析。一致性(c)统计用于检验生存模型的预测准确性。

结果

BMI 分布为 17%肥胖、35%超重、36%正常体重和 12%体重不足。所有 BMI 类别中的患者在体重减轻、肌肉指数和肌肉衰减方面差异很大。使用最佳分层确定了这三个变量与生存之间关联的阈值。高体重减轻、低肌肉指数和低肌肉衰减与生存独立相关。包含常规协变量(癌症诊断、分期、年龄、体能状态)的生存模型的 c 统计值为 0.73(95%CI,0.67 至 0.79),而忽略常规变量并仅包含 BMI、体重减轻、肌肉指数和肌肉衰减的模型的 c 统计值为 0.92(95%CI,0.88 至 0.95;P<0.001)。无论患者是否表现为肥胖、超重、正常体重或体重不足,如果存在这三个预后不良的变量,其存活时间为 8.4 个月(95%CI,6.5 至 10.3),而没有这些特征的患者存活时间为 28.4 个月(95%CI,24.2 至 32.6;P<0.001)。

结论

CT 图像显示出隐匿性肌肉减少。通过传统标准(非自愿体重减轻)和另外两个标准(肌肉减少和低肌肉衰减)判断为恶病质的癌症患者,无论总体体重如何,预后均较差。

相似文献

1
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.肥胖时代的癌症恶病质:骨骼肌消耗是一个强大的预后因素,与体重指数无关。
J Clin Oncol. 2013 Apr 20;31(12):1539-47. doi: 10.1200/JCO.2012.45.2722. Epub 2013 Mar 25.
2
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.非小细胞肺癌患者的身体成分:使用计算机断层扫描图像分析的癌症恶病质的现代观点。
Am J Clin Nutr. 2010 Apr;91(4):1133S-1137S. doi: 10.3945/ajcn.2010.28608C. Epub 2010 Feb 17.
3
Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.恶病质是否与胃肠道癌症患者的化疗毒性相关?一项前瞻性研究。
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):445-454. doi: 10.1002/jcsm.12391. Epub 2019 Mar 28.
4
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.呼吸及胃肠道实体肿瘤患者中肌肉减少性肥胖的患病率及临床意义:一项基于人群的研究
Lancet Oncol. 2008 Jul;9(7):629-35. doi: 10.1016/S1470-2045(08)70153-0. Epub 2008 Jun 6.
5
Elevated Serum AA/EPA Ratio as a Predictor of Skeletal Muscle Depletion in Cachexic Patients with Advanced Gastro-intestinal Cancers.血清AA/EPA比值升高作为晚期胃肠道癌症恶病质患者骨骼肌消耗的预测指标
In Vivo. 2017 Sep-Oct;31(5):1003-1009. doi: 10.21873/invivo.11161.
6
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.骨骼肌放射密度对晚期非小细胞肺癌患者的生存具有预后价值。
Clin Nutr. 2016 Dec;35(6):1386-1393. doi: 10.1016/j.clnu.2016.03.010. Epub 2016 Apr 1.
7
Assessing cachexia in obesity: contradiction or perfectly possible?评估肥胖中的恶病质:矛盾还是完全可能?
Curr Opin Clin Nutr Metab Care. 2024 Sep 1;27(5):387-392. doi: 10.1097/MCO.0000000000001054. Epub 2024 Jul 4.
8
Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.诊断后体重减轻作为非小细胞肺癌的预后因素。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):86-92. doi: 10.1002/jcsm.12253. Epub 2017 Dec 4.
9
Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.癌症恶病质的诊断标准:与未经选择的姑息治疗患者的生活质量、运动能力和生存的关系。
Support Care Cancer. 2013 Jun;21(6):1569-77. doi: 10.1007/s00520-012-1697-z. Epub 2013 Jan 13.
10
Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.体重指数及体重变化对肺癌手术术后结局的预后价值
Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):560-6. doi: 10.1093/icvts/ivw175. Epub 2016 May 31.

引用本文的文献

1
Amino Acids Supplementation in Cancer: What Do We Feed, the Patient or the Tumor?癌症中的氨基酸补充:我们喂的是什么,是患者还是肿瘤?
Nutrients. 2025 Aug 29;17(17):2813. doi: 10.3390/nu17172813.
2
Malnutrition and Nutrition Impact Symptoms in Kuwaiti Colorectal Cancer Patients: Validation of PG-SGA Short Form.科威特结直肠癌患者的营养不良及营养影响症状:患者整体主观全面评定简表的验证
Nutrients. 2025 Aug 27;17(17):2770. doi: 10.3390/nu17172770.
3
Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis.
通过形态功能评估和线粒体生物标志物(生长分化因子15和过氧化物酶体增殖物激活受体γ共激活因子1α)对特发性肺纤维化恶病质进行表型分析
Nutrients. 2025 Aug 24;17(17):2739. doi: 10.3390/nu17172739.
4
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab.低fT3/fT4比值作为帕博利珠单抗治疗的晚期非小细胞肺癌患者肌肉消耗的替代指标。
Front Oncol. 2025 Aug 27;15:1635321. doi: 10.3389/fonc.2025.1635321. eCollection 2025.
5
Molecular subtypes of human skeletal muscle in cancer cachexia.癌症恶病质中人类骨骼肌的分子亚型
Nature. 2025 Sep 10. doi: 10.1038/s41586-025-09502-0.
6
Analysis of the impact of focused psychological nursing combined with enteral nutrition during chemotherapy for colorectal cancer: A retrospective cohort study.聚焦心理护理联合肠内营养对结直肠癌化疗影响的分析:一项回顾性队列研究
Medicine (Baltimore). 2025 Aug 29;104(35):e43318. doi: 10.1097/MD.0000000000043318.
7
Assessment of Sarcopenia in Patients with Liver Cirrhosis-A Literature Review.肝硬化患者肌肉减少症的评估——文献综述
Nutrients. 2025 Aug 9;17(16):2589. doi: 10.3390/nu17162589.
8
Impact of Preoperative CT-Diagnosed Sarcopenic Obesity on Outcomes After Radical Cystectomy for Bladder Cancer.术前CT诊断的肌少症肥胖对膀胱癌根治性膀胱切除术后结局的影响。
Cancers (Basel). 2025 Aug 15;17(16):2669. doi: 10.3390/cancers17162669.
9
Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia: The PREHEP Randomized Clinical Trial.运动与营养预康复以降低肌少症患者肝大部切除术后发病率:PREHEP随机临床试验
JAMA Surg. 2025 Aug 27. doi: 10.1001/jamasurg.2025.3102.
10
Obesity Selectively Increases Intraoperative Risk in Left-Sided Colon Cancer Surgery: A Retrospective Cohort Study.肥胖选择性增加左侧结肠癌手术的术中风险:一项回顾性队列研究
Int J Colorectal Dis. 2025 Aug 25;40(1):188. doi: 10.1007/s00384-025-04989-5.